Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Organon & Q3 2026 Results: Net Income $164M, Up 2.5% YoY

Organon & Co. reported a slight decrease in quarterly revenues to $1.57 billion for Q3 2026, though net income rose to $164 million compared to $160 million in the prior year period. The company significantly strengthened its cash position to $1.46 billion, bolstered by $433 million in proceeds from the sale of Jada.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1,574.01,602.0
Gross profit869.0857.0
Profit before tax255.0243.0
Net income164.0160.0
EPS (diluted, $ a share)$0.60$0.61

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+2.5%
Revenue, year on year-1.7%
Gross margin55.2%
Source

10-Q filed with the SEC, NYSE: OGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Organon & Co.: key numbers

Share price
$13.90Close, Nov 16
Market cap
$3.65B
Shares outstanding
262.62MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Organon & Co.

All →
8:17 AM ET 8-K
M&A Deal

Organon & M&A Deal with Sun Pharmaceutical Industries Limited

Organon & Co. provided a status update on its pending merger with Sun Pharmaceutical Industries Limited, noting that it has suspended customary earnings calls and press releases due to the transaction. The company furnished supplemental non-GAAP financial metrics for the third quarter of 2026 in lieu of a formal earnings release while the merger remains active.

Counterparty
Sun Pharmaceutical Industries Limited

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.